Hong S, Park H, Choi S
Child Health Nurs Res. 2022; 25(1):9-16.
PMID: 35004393
PMC: 8650899.
DOI: 10.4094/chnr.2019.25.1.9.
Tabone M, Kolta S, Auquier P, Vercasson C, Chastagner P, Kanold J
Hemasphere. 2021; 5(2):e518.
PMID: 33458594
PMC: 7806242.
DOI: 10.1097/HS9.0000000000000518.
Lappin K, Davis L, Matchett K, Ge Y, Mills K, Blayney J
Sci Rep. 2020; 10(1):18514.
PMID: 33116257
PMC: 7595190.
DOI: 10.1038/s41598-020-75453-3.
Mueske N, Mittelman S, Wren T, Gilsanz V, Orgel E
Leuk Lymphoma. 2019; 60(13):3146-3153.
PMID: 31264493
PMC: 6923569.
DOI: 10.1080/10428194.2019.1623889.
Peckham-Gregory E, Ton M, Rabin K, Danysh H, Scheurer M, Lupo P
Int J Environ Res Public Health. 2019; 16(11).
PMID: 31181608
PMC: 6603856.
DOI: 10.3390/ijerph16112029.
A Bayesian multivariate latent t-regression model for assessing the association between corticosteroid and cranial radiation exposures and cardiometabolic complications in survivors of childhood acute lymphoblastic leukemia: a PETALE study.
Caubet Fernandez M, Drouin S, Samoilenko M, Morel S, Krajinovic M, Laverdiere C
BMC Med Res Methodol. 2019; 19(1):100.
PMID: 31088361
PMC: 6515639.
DOI: 10.1186/s12874-019-0725-9.
Hepatic late adverse effects after antineoplastic treatment for childhood cancer.
Mulder R, Bresters D, van den Hof M, Koot B, Castellino S, Loke Y
Cochrane Database Syst Rev. 2019; 4:CD008205.
PMID: 30985922
PMC: 6463806.
DOI: 10.1002/14651858.CD008205.pub3.
Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.
Kooijmans E, Bokenkamp A, Tjahjadi N, Tettero J, van Dulmen-den Broeder E, van der Pal H
Cochrane Database Syst Rev. 2019; 3:CD008944.
PMID: 30855726
PMC: 6410614.
DOI: 10.1002/14651858.CD008944.pub3.
Very long intergenic non-coding RNA transcripts and expression profiles are associated to specific childhood acute lymphoblastic leukemia subtypes.
Caron M, St-Onge P, Drouin S, Richer C, Sontag T, Busche S
PLoS One. 2018; 13(11):e0207250.
PMID: 30440012
PMC: 6237371.
DOI: 10.1371/journal.pone.0207250.
Assessment of Health-Related Quality of Life in Pediatric Acute Lymphoblastic Leukemia Survivors: Perceptions of Children, Siblings, and Parents.
Kizmazoglu D, Sari S, Evim Sezgin M, Kantarcioglu A, Tufekci O, Demir Yenigurbuz F
Turk J Haematol. 2018; 36(2):112-116.
PMID: 30401658
PMC: 6516105.
DOI: 10.4274/tjh.galenos.2018.2018.0351.
Investigation of the Relationship Between and Gene Polymorphisms and Development of Treatment-Related Bone Complications in Children with Acute Lymphoblastic Leukemia.
Erdem M, Tufekci O, Kizildag S, Yilmaz S, Kizmazoglu D, Filibeli B
Turk J Haematol. 2018; 36(1):12-18.
PMID: 30251958
PMC: 6373515.
DOI: 10.4274/tjh.galenos.2018.2018.0221.
Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia.
Vanden Bempt M, Demeyer S, Broux M, De Bie J, Bornschein S, Mentens N
Cancer Cell. 2018; 34(2):271-285.e7.
PMID: 30107177
PMC: 6097876.
DOI: 10.1016/j.ccell.2018.07.007.
Physical training interventions for children and teenagers affected by acute lymphoblastic leukemia and related treatment impairments.
Simioni C, Zauli G, Martelli A, Vitale M, Ultimo S, Milani D
Oncotarget. 2018; 9(24):17199-17209.
PMID: 29682216
PMC: 5908317.
DOI: 10.18632/oncotarget.24762.
Predictors of hepatotoxicity and pancreatitis in children and adolescents with acute lymphoblastic leukemia treated according to contemporary regimens.
Denton C, Rawlins Y, Oberley M, Bhojwani D, Orgel E
Pediatr Blood Cancer. 2017; 65(3).
PMID: 29218844
PMC: 7522002.
DOI: 10.1002/pbc.26891.
Association of dietary patterns with overweight risk and all-cause mortality in children with cancer.
So E, Kim J, Joo S, Lee J, Joung H
Nutr Res Pract. 2017; 11(6):492-499.
PMID: 29209460
PMC: 5712500.
DOI: 10.4162/nrp.2017.11.6.492.
Medical and Psychiatric Comorbidities in Korean Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
Park K, Lee J, Kim H
Psychiatry Investig. 2017; 14(6):817-824.
PMID: 29209386
PMC: 5714724.
DOI: 10.4306/pi.2017.14.6.817.
Evaluation of Metabolic Syndrome and Related Factors in Children Affected by Acute Lymphoblastic Leukemia.
Zareifar S, Haghpanah S, Shorafa E, Shakibazad N, Karamizadeh Z
Indian J Med Paediatr Oncol. 2017; 38(2):97-102.
PMID: 28900314
PMC: 5582576.
DOI: 10.4103/ijmpo.ijmpo_69_16.
A randomized controlled trial testing an adherence-optimized Vitamin D regimen to mitigate bone change in adolescents being treated for acute lymphoblastic leukemia.
Orgel E, Mueske N, Sposto R, Gilsanz V, Wren T, Freyer D
Leuk Lymphoma. 2017; 58(10):2370-2378.
PMID: 28278717
PMC: 5489365.
DOI: 10.1080/10428194.2017.1289526.
Brain structure, working memory and response inhibition in childhood leukemia survivors.
van der Plas E, Schachar R, Hitzler J, Crosbie J, Guger S, Spiegler B
Brain Behav. 2017; 7(2):e00621.
PMID: 28239531
PMC: 5318374.
DOI: 10.1002/brb3.621.
Evaluation of Endocrine Late Complications in Childhood Acute Lymphoblastic Leukemia Survivors: A Report of a Single-Center Experience and Review of the Literature.
Bayram C, Yarali N, Fettah A, Demirel F, Tavil B, Kara A
Turk J Haematol. 2016; 34(1):40-45.
PMID: 27094350
PMC: 5451687.
DOI: 10.4274/tjh.2015.0332.